```html

Kongenital Adrenal Hyperplasia (CAH) – A Patient‑Friendly Medical Guide

Overview

Kongenital adrenal hyperplasia (CAH) is a group of inherited disorders that affect the adrenal glands – two small glands perched above the kidneys. The adrenal glands produce vital hormones such as cortisol, aldosterone, and adrenal androgens. In CAH, an enzyme needed to make these hormones is missing or not working properly, leading to hormone imbalances.

• Who it affects: Both males and females are born with CAH. The condition is present from birth, but symptoms can appear at different ages depending on severity.
• Prevalence: The most common form (21‑hydroxylase deficiency) occurs in about 1 in 15,000 live births worldwide, but carrier frequency is higher—approximately 1 in 60 people carries a single defective gene.
• Types:
  • Classic (severe) – further divided into “salt‑wasting” (≈75% of classic cases) and “simple virilizing”.
  • Non‑classic (mild) – often presents later in childhood or adulthood.

Understanding CAH is essential because early detection and lifelong management can prevent life‑threatening crises and improve quality of life.

Symptoms

Symptoms vary widely based on the specific enzyme deficiency and whether the form is classic or non‑classic.

Classic Salt‑Wasting CAH (21‑hydroxylase deficiency)

• Neonatal adrenal crisis: vomiting, poor feeding, lethargy, low blood pressure, hyponatremia (low sodium), hyperkalemia (high potassium).
• Excessive androgen production: virilization of female genitalia (enlarged clitoris, fused labia) detectable at birth; rapid growth of facial/body hair in both sexes.
• Electrolyte disturbances: dehydration, salt loss, low blood pressure.

Classic Simple‑Virilizing CAH

• Similar androgen excess as above but without severe salt loss.
• In females, ambiguous genitalia at birth; in males, early puberty signs (pubic hair, enlarged penis).

Non‑Classic (Late‑Onset) CAH

• Accelerated growth and early closure of growth plates → short adult stature.
• Acne, hirsutism (excess hair on face, chest, abdomen), and irregular menstrual periods in women.
• Infertility or subfertility.
• Occasional mild electrolyte changes, usually not life‑threatening.

Symptoms Common to All Forms

• Fatigue, low energy.
• Salt craving (in salt‑wasting forms).
• Weight gain or difficulty losing weight.
• Psychological effects – anxiety, mood swings.

Causes and Risk Factors

CAH is caused by mutations in genes that code for enzymes involved in steroidogenesis. The most frequent mutation affects the CYP21A2 gene, which encodes the enzyme 21‑hydroxylase.

• Genetic inheritance: Autosomal recessive. A child must inherit two defective copies (one from each parent) to develop classic CAH. One defective copy makes a carrier, who is usually asymptomatic.
• Population risk: Higher carrier rates in certain ethnic groups – e.g., Ashkenazi Jews, Mediterranean, Middle Eastern, and some Native American populations.
• Family history: Having a sibling or parent with CAH increases risk.

Diagnosis

Because CAH can present at any age, a combination of clinical evaluation and laboratory testing is used.

Newborn Screening

• Most developed countries include CAH (21‑hydroxylase deficiency) in routine newborn blood‑spot screening. Elevated 17‑hydroxyprogesterone (17‑OHP) triggers a repeat test.

Laboratory Tests

• 17‑Hydroxyprogesterone (17‑OHP): Primary screening marker; markedly elevated in classic CAH.
• Electrolytes: Low sodium, high potassium in salt‑wasting forms.
• Renin activity & aldosterone: Elevated renin and low aldosterone indicate mineralocorticoid deficiency.
• Androgen levels: Testosterone, DHEA‑S, and androstenedione are often high.
• ACTH Stimulation Test: Measures hormone response after administering synthetic ACTH; confirms enzyme deficiency severity.

Genetic Testing

Sequencing of the CYP21A2 gene (or other relevant genes) identifies specific mutations and helps with family counseling.

Imaging (rarely needed)

• Pelvic ultrasound in females with ambiguous genitalia.
• Adrenal CT/MRI if an adrenal tumor is suspected (unrelated to CAH).

Treatment Options

Management aims to replace deficient hormones, suppress excess androgen production, and prevent adrenal crises.

Glucocorticoid Replacement

• Hydrocortisone: Preferred for infants and children because of its short half‑life, mimicking natural cortisol rhythms.
• Prednisone / Dexamethasone: Used in older children/adults when tighter androgen suppression is needed, but they have longer activity and higher risk of growth suppression.
• Dosage is individualized; frequent monitoring avoids over‑ or under‑replacement.

Mineralocorticoid Replacement (salt‑wasting forms)

• Fludrocortisone: Replaces aldosterone, helps retain sodium and excrete potassium.
• Patients may also need liberal salt intake, especially in hot weather or during illness.

Androgen Suppression

• Higher‑dose glucocorticoids often reduce excess androgen production.
• In some women, anti‑androgen medications (e.g., spironolactone) or oral contraceptives are added for cosmetic concerns.

Stress‑Dosing Protocol

During illness, surgery, or injury, the body needs more cortisol. Patients are taught to double or triple their usual glucocorticoid dose, and use injectable hydrocortisone if they cannot keep oral medication down.

Surgical Management (primarily for females with ambiguous genitalia)

• Genital reconstruction (clitoroplasty, vaginoplasty) is often performed in infancy or early childhood, though timing is individualized and increasingly discussed with families and ethics experts.
• Fertility‑preserving techniques are preferred.

Lifestyle Adjustments

• Regular follow‑up with an endocrinologist.
• Education on recognizing early signs of adrenal crisis.
• Medical alert bracelets and emergency steroid kits.

Living with Kongenital Adrenal Hyperplasia (CAH)

With proper treatment, most people with CAH lead active, healthy lives. Below are practical tips for daily management.

Medication Adherence

• Set alarms or use a pill‑organizer to take doses at the same times each day.
• Carry a small “steroid kit” (hydrocortisone tablets, syringes) for emergencies.

Nutrition & Hydration

• Salt‑wasting patients should add a pinch of salt to meals or use electrolyte drinks, especially in hot climates.
• Balanced diet rich in calcium and vitamin D supports bone health (glucocorticoids can decrease bone density).

Physical Activity

• Exercise is encouraged; however, vigorous activity in hot weather may increase sodium loss—adjust salt intake accordingly.

Growth & Puberty Monitoring

• Regular height and weight checks; adjust glucocorticoid dose to prevent growth suppression.
• Endocrinologist may use growth‑promoting therapies (e.g., growth hormone) if needed.

Fertility & Pregnancy

• Women with CAH often have successful pregnancies with close endocrine monitoring and dose adjustments.
• Pre‑conception counseling is recommended to optimize hormone levels.

Psychosocial Support

• Join support groups (e.g., CARES – CAH Advocacy, Research, Education & Support).
• Consider counseling for body‑image issues, especially in those who had genital surgery.

Prevention

Because CAH is genetic, primary prevention focuses on informed family planning.

• Carrier screening: Recommended for couples with a known family history or belonging to high‑risk ethnic groups.
• Pre‑implantation genetic diagnosis (PGD): Allows selection of embryos without the disease during in‑vitro fertilization.
• Prenatal testing: Chorionic villus sampling (CVS) or amniocentesis can diagnose CAH early; dexamethasone therapy may be offered to reduce virilization in affected female fetuses (controversial and should be discussed with a specialist).

Complications

If not properly managed, CAH can lead to several serious health issues.

• Adrenal crisis: Life‑threatening drop in blood pressure, shock, and possible death.
• Growth impairment: Excess glucocorticoids can stunt growth; insufficient control leads to early epiphyseal closure.
• Infertility: Due to hormonal imbalance or scarring after genital surgery.
• Osteoporosis: Chronic high‑dose steroids weaken bones.
• Metabolic syndrome: Increased risk of obesity, hypertension, and type‑2 diabetes.
• Psychological effects: Anxiety, depression, or gender dysphoria related to atypical genitalia.

When to Seek Emergency Care

---

References:

• Mayo Clinic. “Congenital adrenal hyperplasia.” Link
• National Institutes of Health (NIH). “Congenital adrenal hyperplasia (CAH).” Genetic and Rare Diseases Information Center. Link
• Endocrine Society Clinical Practice Guideline: “Management of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.” Journal of Clinical Endocrinology & Metabolism, 2018.
• World Health Organization. “Newborn Screening and Congenital Adrenal Hyperplasia.” Link
• Cleveland Clinic. “Congenital adrenal hyperplasia (CAH).” Link

```